Wei Zhang

26PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 28, 2026
Baseline Monoclonal Protein Identifies Plasmacytic Differentiation and Shorter Progression-Free Survival in Marginal Zone Lymphoma.

|Oct 20, 2026
A multicentre phase III clinical trial of dual-epigenetic therapy plus CHOP compared with CHOP in previously untreated patients with peripheral T-cell lymphoma.

|Oct 11, 2026
Accelerated Glofitamab as Urgent Bridging to CAR T-Cell Therapy in High-Risk Relapsed/Refractory Large B-Cell Lymphoma.

|Jun 15, 2026
Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.

|Apr 24, 2026
UNC13D in Familial Hemophagocytic Lymphohistiocytosis and Beyond: Functional Mechanisms, Genetic Variants, Multisystem Disease Spectrum and Clinical Implications.

|Feb 11, 2026
Clonal haematopoiesis in T-follicular helper cell lymphoma: A prognostic biomarker and early event in lymphoma evolution.

Chong Wei, Yan Zhang, Danqing Zhao

Pageof 5

Frequent Collaborators

10 joint publications

DaoBin Zhou

8 joint publications

Yan Zhang

6 joint publications

Wei Chong

4 joint publications

Zhiming Li